CoChat

Trovafloxacin-Induced Acute Hepatitis

Lucena, M. I., Andrade, R. J., Rodrigo, L., Salmeron, J., Alvarez, A., Lopez-Garrido, M. J., Camargo, R., Alcantara, R. · 2000 · Clinical Infectious Diseases
Cited by 95

The DOI matches its Crossref record.

Abstract

Trovafloxacin, a new trifluoronaphthyridone derivative related to fluoroquinolone antimicrobial drugs, appears to be more effective than available quinolones. As a class, the most common adverse effects involve the CNS and gastrointestinal tract [1]. Liver enzyme abnormalities have been noted in 2%-3% of patients, and liver toxicity is reported infrequently [2]. Since use of this drug in the United States was authorized in December 1997, 152 cases of serious hepatic events probably related to trovafloxacin have been reported to the US Food and Drug Administration (140 cases) and to the European Agency for the Evaluation of Medicinal Products (12 cases as of July 1998). Because the frequency of serious adverse reactions to trovafloxacin was well out of proportion to that seen in other drugs in this class, the manufacturer withdrew trovafloxacin from the European markets on 15 June 1999. The drug remains available in the United States for very restricted indications [3]. We report 3 patients who had acute hepatitis after taking trovafloxacin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/313680

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 95

Metadata

Authors
Lucena, M. I., Andrade, R. J., Rodrigo, L., Salmeron, J., Alvarez, A., Lopez-Garrido, M. J., Camargo, R., & Alcantara, R.
Venue
Clinical Infectious Diseases
Published
2000-02-01
Volume
30
Issue
2
Pages
400-401
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2153214289
Cited by
95
References
0
FWCI
3.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trovafloxacin-Induced Acute Hepatitis. https://app.cochat.ai/papers/10.1086/313680
The paper
Lucena, M. I., Andrade, R. J., Rodrigo, L., Salmeron, J., Alvarez, A., Lopez-Garrido, M. J., Camargo, R., & Alcantara, R. (2000). Trovafloxacin-Induced Acute Hepatitis. Clinical Infectious Diseases. https://doi.org/10.1086/313680

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.